Abstract
Background: Severe disease of COVID-19 and mortality occur more frequently in male patients than that in female patients may be related to testosterone level. However, the diagnostic value of changes in the level of testosterone in predicting severe disease of male COVID-19 patients has not been determined yet.
Methods: Sixty-one male COVID-19 patients admitted to the First Affiliated Hospital of Zhejiang University School of Medicine were enrolled. Serum samples at different stages of the patients after admission were collected and testosterone levels were detected to analyze the correlation between testosterone level and disease severity. Transcriptome analysis of PBMC was performed in 34 patients.
Results: Testosterone levels at admission in male non-ICU COVID-19 patients (3.7 nmol/L, IQR: 1.5 ∼ 4.7) were significantly lower than those in male ICU COVID-19 patients (6.7 nmol/L, IQR: 4.2 ∼ 8.7). Testosterone levels in the non-ICU group increased gradually during the progression of the disease, while those in the ICU group remained low. In addition, testosterone level of enrolled patients in the second week after onset was significantly correlated with the severity of pneumonia, and ROC curve showed that testosterone level in the second week after onset was highly effective in predicting the severity of COVID-19. Transcriptome studies have found that testosterone levels of COVID-19 patients were associated with immune response, including T cell activation and regulation of lymphocyte activation. In addition, CD28 and Inositol Polyphosphate-4-Phosphatase Type II B (INPP4B) were found positively correlated with testosterone.
Conclusions: Serum testosterone is an independent risk factor for predicting the severity of COVID-19 in male patients, and the level of serum testosterone in the second week after onset is valuable for evaluating the severity of COVID-19. Testosterone level is associated with T cell immune activation. The monitoring of serum testosterone should be highlighted in clinical treatment and the related mechanism should be further studied.
Keywords: COVID-19; Severity; T cell; Testosterone; Transcriptome.
【저자키워드】 COVID-19, Transcriptome, severity, Testosterone, T cell, 【초록키워드】 Transcriptome, immune response, Mortality, Pneumonia, disease severity, Testosterone, progression, ICU, Medicine, lymphocyte, serum, T cell, immune activation, severity of COVID-19, male, Patient, PBMC, School, correlation, university, disease, Admission, transcriptome analysis, patients, mechanism, T cell activation, Clinical treatment, severe disease, COVID-19 patient, ROC Curve, Affiliated Hospital, Activation, Regulation, serum samples, diagnostic value, non-ICU, Stage, Female patients, independent risk factor, CD28, serum sample, significantly lower, Zhejiang, Inositol, effective, INPP4B, enrolled, collected, significantly, the patient, addition, remained, the disease, was performed, changes in, occur, correlated, Type, female patient, positively correlated, 【제목키워드】 Testosterone, immune modulation, male, T-cell, predict, Analysis, COVID-19 patient,